Goldman Sachs Group Inc Syros Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 14, 2024	BUY	$0.69 - $1.21 $167,716 - $294,112	243,068 New	243,068 $234,000
Q2 2022 Aug 15, 2022	BUY	$0.69 - $1.21 $18,261 - $32,023	26,466 Added 12.22%	243,068 $234,000
Q1 2022 May 16, 2022	SELL	$1.02 - $3.8 $283,857 - $1.06 Million	-278,292 Reduced 56.23%	216,602 $257,000
Q4 2021 Feb 14, 2022	BUY	$3.26 - $4.66 $14,321 - $20,471	4,393 Added 0.9%	494,894 $1.61 Million
Q3 2021 Nov 10, 2021	BUY	$4.08 - $5.66 $2 Million - $2.78 Million	490,501 New	490,501 $2.19 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.